Deutsche Bank’s VolitionRx Ltd VNRX Stock Holding History

Deutsche Bank’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,256	Closed	-$95K	–	4811
2021 Q1	$95K	Buy	1,256 +27	+2%	+$2.32K	﹤0.01%	4006
2020 Q4	$96K	Buy	1,229 +544	+79%	+$37.5K	﹤0.01%	3863
2020 Q3	$44K	Buy	685 +144	+27%	+$9.79K	﹤0.01%	3943
2020 Q2	$42K	Buy	+541	New	+$39.1K	﹤0.01%	3892
2020 Q1	–	Sell	-200	Closed	-$18K	–	4853
2019 Q4	$18K	Buy	200 +22	+12%	+$2.28K	﹤0.01%	4336
2019 Q3	$20K	Buy	+178	New	+$14.2K	﹤0.01%	4324
2015 Q2	–	Sell	-5	Closed	–	–	5478
2015 Q1	$0	Buy	+5	New	+$414	﹤0.01%	5984

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's VNRX Position: Q2 2021 in Review

Deutsche Bank sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 1,256 shares — an estimated $95K sold.

Deutsche Bank first reported a position in VNRX in Q1 2015 and held it in 7 quarters. The position peaked at $96K in Q4 2020. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

Deutsche Bank reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
Deutsche Bank sold 1,256 VolitionRx Ltd shares in Q2 2021, an estimated $95K.
Deutsche Bank first reported a position in VolitionRx Ltd in Q1 2015 and held it in 7 quarters.
Deutsche Bank's VolitionRx Ltd position peaked at $96K in Q4 2020.
46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.